(Q37221767)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18640587%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

review article

1 reference

title

Beta-cell apoptosis in type 2 diabetes: quantitative and functional consequences (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18640587%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

0 references

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18640587%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

author name string

R Lupi

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18640587%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

publication date

1 February 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18640587%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

published in

Diabetes and Metabolism

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18640587%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

volume

34 Suppl 2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18640587%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

page(s)

S56-64

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18640587%20AND%20SRC:MED&resulttype=core&format=json

Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM.

11 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973396-2

7 January 2021

Compensatory hyperinsulinemia and the development of an atherogenic lipoprotein profile: the price paid to maintain glucose homeostasis in insulin-resistant individuals

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973396-2

7 January 2021

The natural history of diabetes-related complications: the UKPDS experience. United Kingdom Prospective Diabetes Study

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973396-2

7 January 2021

Different mechanisms for impaired fasting glucose and impaired postprandial glucose tolerance in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973396-2

7 January 2021

Beta-cell deterioration determines the onset and rate of progression of secondary dietary failure in type 2 diabetes mellitus: the 10-year follow-up of the Belfast Diet Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973396-2

7 January 2021

No decrease of the beta-cell mass in type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973396-2

7 January 2021

Cellular composition of the human diabetic pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973396-2

7 January 2021

Functional and molecular defects of pancreatic islets in human type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973396-2

7 January 2021

Pancreatic islets from type 2 diabetic patients have functional defects and increased apoptosis that are ameliorated by metformin.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973396-2

7 January 2021

Early-onset type 2 diabetes in obese white subjects is characterised by a marked defect in beta cell insulin secretion, severe insulin resistance and a lack of response to aerobic exercise training

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973396-2

7 January 2021

Increased beta-cell apoptosis prevents adaptive increase in beta-cell mass in mouse model of type 2 diabetes: evidence for role of islet amyloid formation rather than direct action of amyloid

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973396-2

7 January 2021

Pancreatic islet dysfunction in type 2 diabetes: a rational target for incretin-based therapies

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973396-2

7 January 2021

beta-cell failure in diabetes and preservation by clinical treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973396-2

7 January 2021

Role of apoptosis in failure of beta-cell mass compensation for insulin resistance and beta-cell defects in the male Zucker diabetic fatty rat

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973396-2

7 January 2021

Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973396-2

7 January 2021

The Fas signaling pathway: more than a paradigm

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973396-2

7 January 2021

Live and let die: regulatory mechanisms in Fas-mediated apoptosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973396-2

7 January 2021

Oxidative stress in neurodegeneration: cause or consequence?

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973396-2

7 January 2021

Mitochondrial enzymes and endoplasmic reticulum calcium stores as targets of oxidative stress in neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973396-2

7 January 2021

ER stress and the unfolded protein response

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973396-2

7 January 2021

Organelle-specific initiation of cell death pathways

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973396-2

7 January 2021

Glucotoxicity and beta-cell failure in type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973396-2

7 January 2021

Gliclazide protects human islet beta-cells from apoptosis induced by intermittent high glucose

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973396-2

7 January 2021

Increased O-glycosylation of insulin signaling proteins results in their impaired activation and enhanced susceptibility to apoptosis in pancreatic beta-cells

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973396-2

7 January 2021

Type 1 diabetes: new perspectives on disease pathogenesis and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973396-2

7 January 2021

Roles of cytokines in the pathogenesis and therapy of type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973396-2

7 January 2021

Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973396-2

7 January 2021

Is there a role for locally produced interleukin-1 in the deleterious effects of high glucose or the type 2 diabetes milieu to human pancreatic islets?

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973396-2

7 January 2021

Beta-cells in type 2 diabetes: a loss of function and mass

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973396-2

7 January 2021

Glucose induces beta-cell apoptosis via upregulation of the Fas receptor in human islets

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973396-2

7 January 2021

Endoplasmic reticulum stress and the development of diabetes: a review

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973396-2

7 January 2021

Protein folding in the endoplasmic reticulum and the unfolded protein response.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973396-2

7 January 2021

The endoplasmic reticulum in pancreatic beta cells of type 2 diabetes patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973396-2

7 January 2021

Leptin modulates beta cell expression of IL-1 receptor antagonist and release of IL-1beta in human islets

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973396-2

7 January 2021

Monounsaturated fatty acids prevent the deleterious effects of palmitate and high glucose on human pancreatic beta-cell turnover and function

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973396-2

7 January 2021

Prolonged exposure to free fatty acids has cytostatic and pro-apoptotic effects on human pancreatic islets: evidence that beta-cell death is caspase mediated, partially dependent on ceramide pathway, and Bcl-2 regulated.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973396-2

7 January 2021

Protein kinase B/Akt prevents fatty acid-induced apoptosis in pancreatic beta-cells (INS-1).

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973396-2

7 January 2021

Fatty acid-induced beta cell apoptosis: a link between obesity and diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973396-2

7 January 2021

Role of nitric oxide in obesity-induced beta cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973396-2

7 January 2021

Glucolipotoxicity: fuel excess and beta-cell dysfunction.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973396-2

7 January 2021

Co-localization of islet amyloid polypeptide and insulin in the B cell secretory granules of the human pancreatic islets

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973396-2

7 January 2021

Reduced amylin release is a characteristic of impaired glucose tolerance and type 2 diabetes in Japanese Americans.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973396-2

7 January 2021

Plasma islet amyloid polypeptide levels in obesity, impaired glucose tolerance and non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973396-2

7 January 2021

Pancreatic amylin and calcitonin gene-related peptide cause resistance to insulin in skeletal muscle in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973396-2

7 January 2021

Inhibitory effect of rat amylin on the insulin responses to glucose and arginine in the perfused rat pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973396-2

7 January 2021

Amylin and the amylin gene: structure, function and relationship to islet amyloid and to diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973396-2

7 January 2021

Human type 2 diabetes: morphological evidence for abnormal beta-cell function

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973396-2

7 January 2021

Endocrine pancreas plasticity under physiological and pathological conditions

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973396-2

7 January 2021

Clinical importance of insulin secretion and its interaction with insulin resistance in the treatment of type 2 diabetes mellitus and its complications

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973396-2

7 January 2021

Islet amyloid: a long-recognized but underappreciated pathological feature of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973396-2

7 January 2021

beta-cell deterioration - prospects for reversal or prevention

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973396-2

7 January 2021

The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973396-2

7 January 2021

Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973396-2

7 January 2021

Islet amyloid develops diffusely throughout the pancreas before becoming severe and replacing endocrine cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973396-2

7 January 2021

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973396-2

7 January 2021

Change in pancreatic B-cell function (HOMA-B) varies in different populations with similar genetic backgrounds but different environments.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973396-2

7 January 2021

Sulfonylurea and glinide reduce insulin content, functional expression of KATP channels, and accelerate apoptotic β-cell death in the chronic phase

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973396-2

7 January 2021

Sulfonylurea induced beta-cell apoptosis in cultured human islets

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973396-2

7 January 2021

Glucose and tolbutamide induce apoptosis in pancreatic beta-cells. A process dependent on intracellular Ca2+ concentration

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973396-2

7 January 2021

Effects of prolonged in vitro exposure to sulphonylureas on the function and survival of human islets

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973396-2

7 January 2021

Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973396-2

7 January 2021

New sources of pancreatic beta-cells

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973396-2

7 January 2021

Beta-cell mass plasticity in type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973396-2

7 January 2021

The influence of amyloid deposits on the islet volume in maturity onset diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973396-2

7 January 2021

Morphometrical analysis on topographical difference in size distribution, number and volume of islets in the human pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973396-2

7 January 2021

Effects of hemipancreatectomy on insulin secretion and glucose tolerance in healthy humans.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973396-2

7 January 2021

Experimental reduction of B-cell mass: implications for the pathogenesis of diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973396-2

7 January 2021

Decrease in beta-cell mass leads to impaired pulsatile insulin secretion, reduced postprandial hepatic insulin clearance, and relative hyperglucagonemia in the minipig

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973396-2

7 January 2021

Mechanisms of impaired fasting glucose and glucose intolerance induced by an approximate 50% pancreatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973396-2

7 January 2021

Regulation of beta-cell mass by hormones and growth factors

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973396-2

7 January 2021

Plasma Insulin Responses to Oral and Intravenous Glucose: Studies in Normal and Diabetic Subjects*

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973396-2

7 January 2021

Plasma insulin responses to oral and venous glucose in various forms of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973396-2

7 January 2021

Glucagon-like peptide 1 enhances glucose tolerance both by stimulation of insulin release and by increasing insulin-independent glucose disposal

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973396-2

7 January 2021

The role of GLP-1 in the life and death of pancreatic beta cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973396-2

7 January 2021

Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973396-2

7 January 2021

Insulinotropic glucagon-like peptide 1 agonists stimulate expression of homeodomain protein IDX-1 and increase islet size in mouse pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973396-2

7 January 2021

Glucagon-like peptide-1 promotes islet cell growth and inhibits apoptosis in Zucker diabetic rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973396-2

7 January 2021

Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973396-2

7 January 2021

Glucagon-like peptide-1 inhibits apoptosis of insulin-secreting cells via a cyclic 5'-adenosine monophosphate-dependent protein kinase A- and a phosphatidylinositol 3-kinase-dependent pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973396-2

7 January 2021

Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973396-2

7 January 2021

Therapeutic approaches to preserve islet mass in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973396-2

7 January 2021

10.1016/S1262-3636(08)73396-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18640587%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

1 reference